BioSpace News Archive

OpenEye Scientific (OpenEye) and CHDI Foundation (CHDI) today announced a research collaboration to identify novel small-molecule therapeutics for Huntington’s disease (HD) utilizing Orion, OpenEye’s cloud-native molecular design platform.

Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), is announcing its COVID-19 strategy, and its intent to contribute to the battle against the ensuing worldwide pandemic. Today, the company announced it entered into an agreement with ADS Biotec , a US company based in Omaha, Nebraska, to distribute its FDA-authorized COVID-19 serology antibody tests that recently received EUA (Emergency Use Authorization). Distribution of

eRAD, a subsidiary of RadNet, Inc., a leading provider of radiology image and data management software solutions, announced today that it successfully performed a completely virtual go-live for Chesapeake Medical Imaging and its six mid-Atlantic facilities.

Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional content of crops, today announced that it will release its financial and business results for the second quarter and first half of 2020 after market close on August 13, 2020 .

Applied DNA Sciences, Inc. (NASDAQ: APDN) announced today that it will report fiscal 2020 third quarter financial results after market close on Thursday, August 6, 2020.

Ra Medical Systems, Inc. (“Ra Medical”) (NYSE: RMED), a commercial-stage medical device company leveraging its advanced excimer laser-based platform for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases, today announced that it has priced a public offering of an aggregate of 34,285,714 shares of common stock (or common stock equivalents),

San Diego, Speid & Associates announces that Drug Development Boot Camp® will take place at The Harvard Club, 374 Commonwealth Avenue, Boston, on November 18-19, 2020., and virtually in real time, for those who cannot attend in person.

The Quick Group has just launched another episode of their QuickConversations podcast, designed to help the pharma, biotech and life science community manage their global supply chain, and keep their critical products and patients safe–utilizing best practices and proven logistics solutions.

More details of the three-month program will be provided in the near future.

NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generation antisense oligonucleotide (ASO) therapies using its scalable PATrOL™ platform to address genetic diseases, announced today that Dietrich Stephan, Chief Executive Officer of NeuBase, will participate in a virtual fireside chat at the BTIG Virtual Biotechnology Conference 2020, being held on August 10 – 11. BTIG Virtual Bio